Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Sybil Green"'
Autor:
Nadine J. Barrett, Leigh Boehmer, Janelle Schrag, Al B. Benson, Sybil Green, Leila Hamroun-Yazid, Alexandra Howson, Khalid Matin, Randall A. Oyer, Lori Pierce, Sanford E. Jeames, Karen Winkfield, Eddy S. Yang, Victoria Zwicker, Suanna Bruinooge, Patricia Hurley, Jen Hanley Williams, Carmen E. Guerra
Publikováno v:
JCO Oncology Practice. 19:e570-e580
PURPOSE: Cancer trial participants do not reflect the racial and ethnic diversity in the population of people with cancer in the United States. As a result of multiple system-, patient-, and provider-level factors, including implicit bias, cancer cli
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5f7b3bf5b802799edef2f314c7b5f897
https://doi.org/10.1200/op.22.00378
https://doi.org/10.1200/op.22.00378
Autor:
Narjust Duma, Ana I. Velazquez, Idalid Franco, Lauren Kiel, Laura A. Levit, Caroline Schenkel, Kelsey Kirkwood, Sybil Green, Gladys Rodriguez
Publikováno v:
JCO Oncol Pract
This manuscript reviews the status of Hispanic/Latinx physicians in oncology, the benefits and challenges to achieving equitable representation, and potential solutions and actions to increase diversity in the oncology workforce. Persons of Hispanic/
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9ca52c5078de5da5798db82116fa048d
https://doi.org/10.1200/op.22.00153
https://doi.org/10.1200/op.22.00153
Autor:
Alexander L. Chin, Deborah Y. Kamin, Ray D. Page, Stephen Grubbs, Mary Rappaport, Sybil Green, Jeffery C. Ward, Brian Bourbeau
Publikováno v:
JCO Oncology Practice. 16:263-269
The past decade has seen considerable innovation in the delivery of care and payment in oncology. Key initiatives have included the development of oncology medical home care delivery standards, the Medicare Oncology Care Model, and multiple commercia
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::41bc6378020c9f5430dd2fe71462e861
https://doi.org/10.1200/jop.19.00776
https://doi.org/10.1200/jop.19.00776
Autor:
Kelsey Kirkwood, Sybil Green, Caroline Schenkel, Laura A. Levit, Michal Tibbits, Lori J. Pierce, Eileen Melnick, Karen M. Winkfield
Publikováno v:
JCO Oncology Practice. 17:224-226
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e4007fe65f4dde0bc7a07b901582183c
https://doi.org/10.1200/op.21.00079
https://doi.org/10.1200/op.21.00079
Autor:
Nadine Barrett, Leigh Boehmer, Janelle Schrag, Al Bowen Benson, Sybil Green, Leila Hamroun, Alexandra Howson, Khalid Matin, Randall A. Oyer, Lori J. Pierce, Sanford Earl Jeames, Karen Marie Winkfield, Eddy Shih-Hsin Yang, Victoria Zwicker, Suanna Steeby Bruinooge, Patricia A. Hurley, Jen Hanley Hanley Williams, Carmen Guerra
Publikováno v:
Journal of Clinical Oncology. 40:e18599-e18599
e18599 Background: Low participation of Black, Hispanic, Latinx and other underrepresented racial/ethnic groups in clinical research remains a problem across the U.S. Recent studies have highlighted that stereotypes, assumptions, and bias play a role
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::950199c912967bf0c33b2de79dbff615
https://doi.org/10.1200/jco.2022.40.16_suppl.e18599
https://doi.org/10.1200/jco.2022.40.16_suppl.e18599
Autor:
Robin Zon, Anne Tsao, Edward P. Balaban, Michael Diaz, Sybil Green, Michael Francisco, R. Donald Harvey, Gary H. Lyman, Richard L. Schilsky, Emile E. Voest, Shimere Sherwood, Andrea Ferris
Publikováno v:
Journal of Clinical Oncology. 36:1260-1265
As many biosimilars come to market in the next several years, their use in oncology will play an important role in the future care of patients with cancer. ASCO is committed to providing education and guidance to the oncology community on the use of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9ab0f743be9f95ee53c4cfde5df344b9
https://doi.org/10.1200/jco.2017.77.4893
https://doi.org/10.1200/jco.2017.77.4893
Autor:
Allyn Moushey, Elizabeth Garrett-Mayer, Stephen C. Meersman, Suanna S. Bruinooge, Sybil Green, Richard L. Schilsky, Stephen Grubbs, Patricia Hurley, Deborah Y. Kamin, Brian Bourbeau
Publikováno v:
Clinical Cancer Research. 26:S06-01
Background: In April 2020, ASCO initiated a registry to capture and analyze status and outcomes of patients with cancer and COVID-19, and to describe effects of the pandemic on U.S. cancer practices. Initial findings of changes to care delivery are i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::44accaf08348c535ace576e6d185f230
https://doi.org/10.1158/1557-3265.covid-19-s06-01
https://doi.org/10.1158/1557-3265.covid-19-s06-01
Autor:
Lyman GH; Gary H. Lyman, Hutchinson Institute for Cancer Outcomes Research, Fred Hutchinson Cancer Research Center, Seattle, WA; Edward Balaban, University of Pennsylvania Medical College, Philadelphia, PA; Michael Diaz, Florida Cancer Specialists and Research Institute, St Petersburg, FL; Andrea Ferris, Lungevity Foundation, Bethesda, MD; Anne Tsao, The University of Texas MD Anderson Cancer Center, Houston, TX; Emile Voest, The Netherlands Cancer Institute, Amsterdam, the Netherlands; Robin Zon, Michiana Hematology Oncology, Mishawaka, IN; Michael Francisco, Sybil Green, Shimere Sherwood, and Richard L. Schilsky, American Society of Clinical Oncology, Alexandria, VA; and R. Donald Harvey, Emory University School of Medicine, Atlanta, GA., Balaban E; Gary H. Lyman, Hutchinson Institute for Cancer Outcomes Research, Fred Hutchinson Cancer Research Center, Seattle, WA; Edward Balaban, University of Pennsylvania Medical College, Philadelphia, PA; Michael Diaz, Florida Cancer Specialists and Research Institute, St Petersburg, FL; Andrea Ferris, Lungevity Foundation, Bethesda, MD; Anne Tsao, The University of Texas MD Anderson Cancer Center, Houston, TX; Emile Voest, The Netherlands Cancer Institute, Amsterdam, the Netherlands; Robin Zon, Michiana Hematology Oncology, Mishawaka, IN; Michael Francisco, Sybil Green, Shimere Sherwood, and Richard L. Schilsky, American Society of Clinical Oncology, Alexandria, VA; and R. Donald Harvey, Emory University School of Medicine, Atlanta, GA., Diaz M; Gary H. Lyman, Hutchinson Institute for Cancer Outcomes Research, Fred Hutchinson Cancer Research Center, Seattle, WA; Edward Balaban, University of Pennsylvania Medical College, Philadelphia, PA; Michael Diaz, Florida Cancer Specialists and Research Institute, St Petersburg, FL; Andrea Ferris, Lungevity Foundation, Bethesda, MD; Anne Tsao, The University of Texas MD Anderson Cancer Center, Houston, TX; Emile Voest, The Netherlands Cancer Institute, Amsterdam, the Netherlands; Robin Zon, Michiana Hematology Oncology, Mishawaka, IN; Michael Francisco, Sybil Green, Shimere Sherwood, and Richard L. Schilsky, American Society of Clinical Oncology, Alexandria, VA; and R. Donald Harvey, Emory University School of Medicine, Atlanta, GA., Ferris A; Gary H. Lyman, Hutchinson Institute for Cancer Outcomes Research, Fred Hutchinson Cancer Research Center, Seattle, WA; Edward Balaban, University of Pennsylvania Medical College, Philadelphia, PA; Michael Diaz, Florida Cancer Specialists and Research Institute, St Petersburg, FL; Andrea Ferris, Lungevity Foundation, Bethesda, MD; Anne Tsao, The University of Texas MD Anderson Cancer Center, Houston, TX; Emile Voest, The Netherlands Cancer Institute, Amsterdam, the Netherlands; Robin Zon, Michiana Hematology Oncology, Mishawaka, IN; Michael Francisco, Sybil Green, Shimere Sherwood, and Richard L. Schilsky, American Society of Clinical Oncology, Alexandria, VA; and R. Donald Harvey, Emory University School of Medicine, Atlanta, GA., Tsao A; Gary H. Lyman, Hutchinson Institute for Cancer Outcomes Research, Fred Hutchinson Cancer Research Center, Seattle, WA; Edward Balaban, University of Pennsylvania Medical College, Philadelphia, PA; Michael Diaz, Florida Cancer Specialists and Research Institute, St Petersburg, FL; Andrea Ferris, Lungevity Foundation, Bethesda, MD; Anne Tsao, The University of Texas MD Anderson Cancer Center, Houston, TX; Emile Voest, The Netherlands Cancer Institute, Amsterdam, the Netherlands; Robin Zon, Michiana Hematology Oncology, Mishawaka, IN; Michael Francisco, Sybil Green, Shimere Sherwood, and Richard L. Schilsky, American Society of Clinical Oncology, Alexandria, VA; and R. Donald Harvey, Emory University School of Medicine, Atlanta, GA., Voest E; Gary H. Lyman, Hutchinson Institute for Cancer Outcomes Research, Fred Hutchinson Cancer Research Center, Seattle, WA; Edward Balaban, University of Pennsylvania Medical College, Philadelphia, PA; Michael Diaz, Florida Cancer Specialists and Research Institute, St Petersburg, FL; Andrea Ferris, Lungevity Foundation, Bethesda, MD; Anne Tsao, The University of Texas MD Anderson Cancer Center, Houston, TX; Emile Voest, The Netherlands Cancer Institute, Amsterdam, the Netherlands; Robin Zon, Michiana Hematology Oncology, Mishawaka, IN; Michael Francisco, Sybil Green, Shimere Sherwood, and Richard L. Schilsky, American Society of Clinical Oncology, Alexandria, VA; and R. Donald Harvey, Emory University School of Medicine, Atlanta, GA., Zon R; Gary H. Lyman, Hutchinson Institute for Cancer Outcomes Research, Fred Hutchinson Cancer Research Center, Seattle, WA; Edward Balaban, University of Pennsylvania Medical College, Philadelphia, PA; Michael Diaz, Florida Cancer Specialists and Research Institute, St Petersburg, FL; Andrea Ferris, Lungevity Foundation, Bethesda, MD; Anne Tsao, The University of Texas MD Anderson Cancer Center, Houston, TX; Emile Voest, The Netherlands Cancer Institute, Amsterdam, the Netherlands; Robin Zon, Michiana Hematology Oncology, Mishawaka, IN; Michael Francisco, Sybil Green, Shimere Sherwood, and Richard L. Schilsky, American Society of Clinical Oncology, Alexandria, VA; and R. Donald Harvey, Emory University School of Medicine, Atlanta, GA., Francisco M; Gary H. Lyman, Hutchinson Institute for Cancer Outcomes Research, Fred Hutchinson Cancer Research Center, Seattle, WA; Edward Balaban, University of Pennsylvania Medical College, Philadelphia, PA; Michael Diaz, Florida Cancer Specialists and Research Institute, St Petersburg, FL; Andrea Ferris, Lungevity Foundation, Bethesda, MD; Anne Tsao, The University of Texas MD Anderson Cancer Center, Houston, TX; Emile Voest, The Netherlands Cancer Institute, Amsterdam, the Netherlands; Robin Zon, Michiana Hematology Oncology, Mishawaka, IN; Michael Francisco, Sybil Green, Shimere Sherwood, and Richard L. Schilsky, American Society of Clinical Oncology, Alexandria, VA; and R. Donald Harvey, Emory University School of Medicine, Atlanta, GA., Green S; Gary H. Lyman, Hutchinson Institute for Cancer Outcomes Research, Fred Hutchinson Cancer Research Center, Seattle, WA; Edward Balaban, University of Pennsylvania Medical College, Philadelphia, PA; Michael Diaz, Florida Cancer Specialists and Research Institute, St Petersburg, FL; Andrea Ferris, Lungevity Foundation, Bethesda, MD; Anne Tsao, The University of Texas MD Anderson Cancer Center, Houston, TX; Emile Voest, The Netherlands Cancer Institute, Amsterdam, the Netherlands; Robin Zon, Michiana Hematology Oncology, Mishawaka, IN; Michael Francisco, Sybil Green, Shimere Sherwood, and Richard L. Schilsky, American Society of Clinical Oncology, Alexandria, VA; and R. Donald Harvey, Emory University School of Medicine, Atlanta, GA., Sherwood S; Gary H. Lyman, Hutchinson Institute for Cancer Outcomes Research, Fred Hutchinson Cancer Research Center, Seattle, WA; Edward Balaban, University of Pennsylvania Medical College, Philadelphia, PA; Michael Diaz, Florida Cancer Specialists and Research Institute, St Petersburg, FL; Andrea Ferris, Lungevity Foundation, Bethesda, MD; Anne Tsao, The University of Texas MD Anderson Cancer Center, Houston, TX; Emile Voest, The Netherlands Cancer Institute, Amsterdam, the Netherlands; Robin Zon, Michiana Hematology Oncology, Mishawaka, IN; Michael Francisco, Sybil Green, Shimere Sherwood, and Richard L. Schilsky, American Society of Clinical Oncology, Alexandria, VA; and R. Donald Harvey, Emory University School of Medicine, Atlanta, GA., Harvey RD; Gary H. Lyman, Hutchinson Institute for Cancer Outcomes Research, Fred Hutchinson Cancer Research Center, Seattle, WA; Edward Balaban, University of Pennsylvania Medical College, Philadelphia, PA; Michael Diaz, Florida Cancer Specialists and Research Institute, St Petersburg, FL; Andrea Ferris, Lungevity Foundation, Bethesda, MD; Anne Tsao, The University of Texas MD Anderson Cancer Center, Houston, TX; Emile Voest, The Netherlands Cancer Institute, Amsterdam, the Netherlands; Robin Zon, Michiana Hematology Oncology, Mishawaka, IN; Michael Francisco, Sybil Green, Shimere Sherwood, and Richard L. Schilsky, American Society of Clinical Oncology, Alexandria, VA; and R. Donald Harvey, Emory University School of Medicine, Atlanta, GA., Schilsky RL; Gary H. Lyman, Hutchinson Institute for Cancer Outcomes Research, Fred Hutchinson Cancer Research Center, Seattle, WA; Edward Balaban, University of Pennsylvania Medical College, Philadelphia, PA; Michael Diaz, Florida Cancer Specialists and Research Institute, St Petersburg, FL; Andrea Ferris, Lungevity Foundation, Bethesda, MD; Anne Tsao, The University of Texas MD Anderson Cancer Center, Houston, TX; Emile Voest, The Netherlands Cancer Institute, Amsterdam, the Netherlands; Robin Zon, Michiana Hematology Oncology, Mishawaka, IN; Michael Francisco, Sybil Green, Shimere Sherwood, and Richard L. Schilsky, American Society of Clinical Oncology, Alexandria, VA; and R. Donald Harvey, Emory University School of Medicine, Atlanta, GA.
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2018 Apr 20; Vol. 36 (12), pp. 1260-1265. Date of Electronic Publication: 2018 Feb 14.